Recruiting Prostate Cancer Studies in Myrtle Beach
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
The purpose of this study is to assess the safety and efficacy of pembrolizumab (MK-3475) combination therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will b...
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in combination with best supportive...
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to treat prostate cancer. It works by reducing the amount of the main male sex hormone, testosterone in the body. Androgen rece...
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
This study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients wi...
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
This Phase II study aims to evaluate efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg once a day (QD) doses + abiraterone compared with an androgen...
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
The goal of this clinical trial is to learn if the vaccine FK-PC101 works to delay or prevent the return of prostate cancer in men who have had surgery to remove their prostate cancer. It will also le...
About Prostate Cancer Clinical Trials in Myrtle Beach
Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.
There are currently 6 prostate cancer clinical trials recruiting participants in Myrtle Beach, SC. These studies are seeking a combined 2,506 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Janssen Research & Development, LLC, Astellas Pharma Global Development, Inc. and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prostate Cancer Clinical Trials in Myrtle Beach — FAQ
Are there prostate cancer clinical trials in Myrtle Beach?
Yes, there are 6 prostate cancer clinical trials currently recruiting in Myrtle Beach, SC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Myrtle Beach?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Myrtle Beach research site will contact you about next steps.
Are clinical trials in Myrtle Beach free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Myrtle Beach studies also compensate for your time and travel.
What prostate cancer treatments are being tested?
The 6 active trials in Myrtle Beach are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.
Data updated March 2, 2026 from ClinicalTrials.gov